Advertisement

Table of Contents

October 01, 2012; Volume 64,Issue 4

Review Articles

  • Purinergic Signaling in the Airways
    Geoffrey Burnstock, Inge Brouns, Dirk Adriaensen and Jean-Pierre Timmermans
    Dianne M. Perez, ASSOCIATE EDITOR, Autonomic Neuroscience Centre, University College Medical School, Royal Free Campus, Rowland Hill Street, London, United Kingdom (G.B.); and University of Antwerp, Groenenborgercampus, Department of Veterinary Sciences, Laboratory of Cell Biology & Histology/Core Facility Biomedical Microscopic Imaging, Antwerpen, Belgium (I.B., D.A., J.-P.T.)
    Pharmacological Reviews October 2012, 64 (4) 834-868; DOI: https://doi.org/10.1124/pr.111.005389
  • Insights into the Neurobiology of the Nicotinic Cholinergic System and Nicotine Addiction from Mice Expressing Nicotinic Receptors Harboring Gain-of-Function Mutations
    Ryan M. Drenan and Henry A. Lester
    Burt M. Sharp, ASSOCIATE EDITOR, Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana (R.M.D.); and Division of Biology, California Institute of Technology, Pasadena, California (H.A.L.)
    Pharmacological Reviews October 2012, 64 (4) 869-879; DOI: https://doi.org/10.1124/pr.111.004671
  • Diabetic Peripheral Neuropathy: Should a Chaperone Accompany Our Therapeutic Approach?
    Kevin L. Farmer, Chengyuan Li and Rick T. Dobrowsky
    Emily E. Scott, ASSOCIATE EDITOR, Department of Pharmacology and Toxicology, University of Kansas, Lawrence, Kansas
    Pharmacological Reviews October 2012, 64 (4) 880-900; DOI: https://doi.org/10.1124/pr.111.005314
  • Unraveling the Time Domains of Corticosteroid Hormone Influences on Brain Activity: Rapid, Slow, and Chronic Modes
    Marian Joëls, R. Angela Sarabdjitsingh and Henk Karst
    Glenda E. Gillies, ASSOCIATE EDITOR, Department of Neuroscience and Pharmacology, Rudolf Magnus Institute, University Medical Center Utrecht, Utrecht, the Netherlands
    Pharmacological Reviews October 2012, 64 (4) 901-938; DOI: https://doi.org/10.1124/pr.112.005892
  • Unravelling the Mystery of Capsaicin: A Tool to Understand and Treat Pain
    Jessica O'Neill, Christina Brock, Anne Estrup Olesen, Trine Andresen, Matias Nilsson and Anthony H. Dickenson
    Annette C. Dolphin, ASSOCIATE EDITOR, Neuroscience, Physiology and Pharmacology, University College London (J.O., A.H.D.); and Mech-Sense, Department of Gastroenterology, Aalborg Hospital, Aarhus University, Denmark (C.B., A.E.O., T.A., M.N.)
    Pharmacological Reviews October 2012, 64 (4) 939-971; DOI: https://doi.org/10.1124/pr.112.006163
  • Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease
    Karen T. Liby and Michael B. Sporn
    Timothy A. Esbenshade, ASSOCIATE EDITOR, Departments of Medicine and Pharmacology, Dartmouth Medical School, Hanover, New Hampshire
    Pharmacological Reviews October 2012, 64 (4) 972-1003; DOI: https://doi.org/10.1124/pr.111.004846
  • Tumor Necrosis Factor-Induced Cerebral Insulin Resistance in Alzheimer's Disease Links Numerous Treatment Rationales
    Ian Clark, Craig Atwood, Richard Bowen, Gilberto Paz-Filho and Bryce Vissel
    David R. Sibley, ASSOCIATE EDITOR, Research School of Biology, Australian National University, Canberra, Australia (I.C.); Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin (C.A.); School of Exercise, Biomedical and Health Sciences, Edith Cowan University, Joondalup, Australia (C.A.); OTB Research, Charleston, South Carolina (R.B.); John Curtin School of Medical Research, Australian National University, Canberra, Australia (G.P.-F.); and the Neurodegeneration Research Group, Garvan Institute of Medical Research, Sydney, Australia (B.V.)
    Pharmacological Reviews October 2012, 64 (4) 1004-1026; DOI: https://doi.org/10.1124/pr.112.005850
  • Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune Diseases and Hematological Malignancies
    John G. Foster, Matthew D. Blunt, Edward Carter and Stephen G. Ward
    David R. Sibley, ASSOCIATE EDITOR, Inflammatory Cell Biology Laboratory, Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath, United Kingdom
    Pharmacological Reviews October 2012, 64 (4) 1027-1054; DOI: https://doi.org/10.1124/pr.110.004051
  • Molecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2
    Qiang Ma and Xiaoqing He
    David R. Sibley, ASSOCIATE EDITOR, Receptor Biology Laboratory, Toxicology and Molecular Biology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia
    Pharmacological Reviews October 2012, 64 (4) 1055-1081; DOI: https://doi.org/10.1124/pr.110.004333
Back to top

In this issue

Jump to

Advertisement